Tag: PD-L1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PD-L1

FLX Bio Completes $60 Million Series C Financing

Added to Collection on: 2017-12-20 20:56:15

Tags for this article:

Biology
Cell biology
Proteins
Immunology
Immune system
Tumor microenvironment
Cancer immunotherapy
Immune checkpoint
FLX Bio Inc.
USP7
Regulatory T cell
TP53
PD-L1
SOUTH SAN FRANCISCO

Click the tags to see associated articles and topics

View Article Details
Cancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPO

Added to Collection on: 2018-01-01 22:48:45

Tags for this article:

Medicine
Clinical medicine
Immune system
PD-L1
Programmed cell death protein 1
Interleukin 15
PDAC
Armo

Click the tags to see associated articles and topics

View Article Details
Cancer Imunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPO

Added to Collection on: 2018-01-01 22:48:45

Tags for this article:

Medicine
Clinical medicine
Immune system
PD-L1
Programmed cell death protein 1
Interleukin 15
PDAC
Armo

Click the tags to see associated articles and topics

View Article Details
Researchers develop new technology platform for cancer immunotherapy

Added to Collection on: 2018-02-22 04:37:30

Tags for this article:

Medicine
Clinical medicine
Immunology
Immune system
Insilico Medicine Inc.
Cancer immunotherapy
Baltimore
Immune checkpoint
Ipilimumab
Pembrolizumab
Regulatory T cell
PD-L1
Programmed cell death protein 1
Checkpoint inhibitor

Click the tags to see associated articles and topics

View Article Details
Johns Hopkins spinout spotlights a showcase animal test for antibody-ligand I/O traps — matching ...

Added to Collection on: 2018-02-25 19:03:24

Tags for this article:

Health
Medicine
Immunology
Insilico Medicine
Immune system
Biotechnology companies
Antibody
Tumor microenvironment
Regulatory T cell
PD-L1
T cells
Programmed cell death protein 1
Atul Bedi

Click the tags to see associated articles and topics

View Article Details
NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD ...

Added to Collection on: 2018-06-02 05:22:30

Tags for this article:

Health
Economy
Nationality
Precision medicine
PD-L1
Patrick Soon-Shiong
NantHealth
NantOmics
NantHealth,Inc.
NantOmics,LLC

Click the tags to see associated articles and topics

View Article Details
NextCure and Yale Publish New Immuno-Oncology Target, Siglec-15

Added to Collection on: 2019-03-04 22:15:00

Tags for this article:

Medicine
Clinical medicine
Cancer
Immunotherapy
Tumor microenvironment
Cancer immunotherapy
PD-L1
Medical specialties

Click the tags to see associated articles and topics

View Article Details
Alpine Immune Sciences Inc (NASDAQ:ALPN) Receives $12.80 Consensus Target Price from ...

Added to Collection on: 2019-06-15 19:48:45

Tags for this article:

Money
Finance
Economy
Stock
Short
Financial analyst
Securities research
Occupations
PD-L1
Alpine Immune Sciences Inc.

Click the tags to see associated articles and topics

View Article Details
Alpine Immune Sciences (NASDAQ:ALPN) Downgraded by ValuEngine to “Sell”

Added to Collection on: 2019-07-24 06:28:56

Tags for this article:

Money
Finance
Hedge fund
Economy
Stock market
Stock
Short
Financial analyst
Securities research
Occupations
PD-L1
Price–earnings ratio
Immune Sciences, Inc

Click the tags to see associated articles and topics

View Article Details
Global Immune Checkpoint Inhibitors Market research Revenue to Record Stellar Growth Rate ...

Added to Collection on: 2019-08-18 14:22:30

Tags for this article:

Medicine
Clinical medicine
Cancer treatments
Immune system
Merck & Co.
Immune checkpoint
PD-L1
Treatment of cancer
Checkpoint inhibitor
Medical specialties
US Dollar

Click the tags to see associated articles and topics

View Article Details